🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "specific measures to address cost of living challenges" in the upcoming financial statement.

In comments to the BBC, she stated that lowering price rises is a joint responsibility of both the administration and the central bank.

The UK's price growth is forecast to be the highest among the Group of Seven industrialized countries this calendar year and next.

Potential Utility Cost Measures

Reports indicate the administration could intervene to bring down utility costs, such as by slashing the current 5% level of VAT charged on energy.

An additional option is to lower some of the policy costs currently added to household expenses.

Budgetary Constraints and Analyst Expectations

The government will receive the latest draft from the official forecaster, the OBR, on Monday, which will show how much space there is for these measures.

The expectation from the majority of analysts is that the Chancellor will have to declare higher taxes or spending cuts in order to fulfill her self-imposed borrowing rules.

Previously on Thursday, analysis suggested there was a £22 billion shortfall for the Treasury chief to address, which is at the lower end of forecasts.

"There's a collective job between the central bank and the government to bear down further on some of the sources of inflation," Reeves stated to the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and Global Issues

While a great deal of the focus has been on expected tax rises, the Treasury chief said the most recent information from the OBR had not changed her commitment to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She attributed an "uncertain world" with rising geopolitical and trade issues for the Budget tax moves, probably to be directed on those "wealthiest."

International Trade Tensions

Referring to worries about the UK's trade ties with the Asian nation she said: "The UK's national security always come first."

Last week's announcement by Chinese authorities to tighten trade restrictions on rare earths and other resources that are essential for high-technology manufacturing led American leader Donald Trump to threaten an further 100% tariff on goods from the Asian country, raising the prospect of an all-out trade war between the two largest economies.

The American finance chief described China's decision "economic coercion" and "a global supply chain power grab."

Asked about considering the American proposal to participate in its dispute with the Asian nation, Reeves said she was "very concerned" by Chinese measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "bad for the international commerce and creates additional obstacles."

"In my view there are sectors where we must address Chinese policies, but there are also significant chances to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also affirmed she was cooperating with other major economies "on our own essential resources approach, so that we are more independent."

Health Service Medicine Pricing and Funding

The Chancellor also recognized that the price the National Health Service spends on pharmaceuticals could go up as a result of ongoing talks with the US government and its pharmaceutical firms, in return for lower tariffs and capital.

A number of the biggest global drug companies have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with several attributing the insufficient payments they are receiving.

Last month, the Science Minister said the price the NHS pays for medicines would must increase to prevent businesses and drug research funding departing from the UK.

Reeves informed the BBC: "It has been observed because of the pricing regime, that medical research, recent pharmaceuticals have not been offered in the UK in the way that they are in other European countries."

"The objective is to ensure that people getting care from the NHS are can obtain the best life-saving medicines in the globe. And so we are reviewing all of that, and... looking to obtain increased funding into Britain."